Results from Novo Nordisk's STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

The building’s design ... In 2018, the world learned Novo Nordisk’s name when the company released semaglutide as Ozempic. Novo even created a jingle. Oh oh oh Ozempic! The cheers for ...

Spain — one of Europe's fastest growing economies, according to the OECD — is set to publish import and export figures on ...

Fifteen drugs, including Novo Nordisk's Ozempic and Wegovy, are slated for Medicare price negotiations under the Inflation ...

The dominance of the US, and its technology companies in particular, has become an accepted feature of global stock markets.

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

A UK biotechnology startup is entering the crowded obesity drug market, armed with $411 million and a promising ...

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...